Home>Topics>Companies>Beckman Coulter

Beckman Coulter BEC

  1. All
  2. Commentary
  3. Stock Reports
  4. Headlines
    1. New Morningstar Analyst Report - Danaher

      Stock Reports

      Fri, 19 Apr 2013

      related to the acquisition of Beckman Coulter will likely cause this ratio ..... completed the acquisition of Beckman Coulter , a leading life sciences and ..... Danaher's recent acquisition of Beckman Coulter heightens the firm's exposure

    2. Danaher Delivers Strong Fourth-Quarter Earnings and Cash Flow

      Commentary

      Thu, 18 Apr 2013

      2011 in the life sciences also stands out as Danaher continues to drive operating improvements from recently acquired Beckman Coulter and AB Sciex. During 2012, Danaher generated $3 billion of free cash flow, a 25% improvement versus the prior

    3. TEXT-S&P summary: Danaher Corp.

      Headlines

      Wed, 14 Nov 2012

      from a large recurring revenue base, margin expansion opportunities in acquired businesses (including the large Beckman Coulter acquisition completed in 2011), and growth initiatives.

    4. Idenix Pharmaceuticals' CEO Discusses Q3 2012 Results - Earnings Call Transcript

      Headlines

      Thu, 1 Nov 2012

      Pharmaceuticals, Inc. ( IDIX ) Q3 2012 Earnings Call November 1, 2012 4:30 PM ET Executives Teri Dahlman – IR Daniella Beckman – SVP and CFO Ron Renaud – President and CEO David Standring – EVP and Chief Scientific Officer Doug Mayers – EVP and

    5. Danaher's Third Quarter Below Expectations, Cash Flow Remains Strong

      Commentary

      Thu, 18 Oct 2012

      in the prior year, after accounting for charges related to the Beckman Coulter acquisition. Our primary concerns for the portfolio reside in the ..... operations is nearly $3.4 billion, driven by strong performance at Beckman Coulter .

    6. Idenix Pharmaceuticals' CEO Provides Update on IDX184 Clinical Development Program Conference (Transcript)

      Headlines

      Fri, 17 Aug 2012

      IDIX ) Update on IDX184 Clinical Development Program Conference Call August 16, 2012 08:30 am ET Executives Daniella Beckman - SVP & CFO Ron Renaud - President & CEO Doug Mayers - EVP & CMO David Standring - EVP & CSO Analysts Geoff Meacham - JPMorgan

    7. Core Revenue Growth Continues to Weaken for Danaher in First Quarter

      Commentary

      Thu, 19 Apr 2012

      think the firm needs a bit more time to drive synergies from Beckman and Esko Artwork. Additionally, the recently announced acquisition ..... onto core margin, but there is only one more quarter that Beckman will not be in the comparisons, and we think the firm may

    8. Internal Revenue Growth Slows in 4Q for Danaher; Beckman Making Strides

      Commentary

      Tue, 31 Jan 2012

      versus the prior year. The addition of Beckman Coulter helped lift revenue another 33%. Beckman 's integration is going well by management's ..... within the firm. The company also noted that Beckman 's working capital has yet to really feel

    9. Ares Capital Corporation ARCC Q3 2011 Earnings Call Transcript

      Headlines

      Tue, 8 Nov 2011

      everyone, and thanks for joining us. I'm joined today by the Senior Partners of Ares Management's Private Debt Group Eric Beckman , Kipp deVeer, Mitchell Goldstein and Michael Smith; our Chief Financial Officer, Penni Roll; and Carl Drake, and Scott

    10. Danaher Reports Solid 3Q

      Commentary

      Thu, 20 Oct 2011

      all of which are outside the Beckman Coulter integration. While nothing seems ..... quarter with recently acquired Beckman folded into the organization ..... Management conceded that core growth at Beckman was essentially flat and the outlook

    « Prev12345Next »
    Content Partners